Clinical Trials · NCT01833078

Ghrelin Repeated Dose Study

CompletedPhase 2GHRP-6 (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
University of Pennsylvania
Enrollment
5
Start date
Feb 2013
Locations
1 site, United States
Primary endpoint
Safety
View Ghrp-6 compound reference